BioCentury
ARTICLE | Company News

Merck, Santen deal

July 21, 2014 7:00 AM UTC

Santen completed its acquisition of rights from Merck to nine ophthalmic products in countries in Europe and Asia-Pacific. Santen paid about $550 million and will pay an additional $50 million, for a ...